Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPalace Capital Regulatory News (PCA)

Share Price Information for Palace Capital (PCA)

Share Price is delayed by 15 minutes
Get Live Data
167.00    2.00 (1.21%)
Bid:
165.50
Ask:
168.50
Spread: 3.00 (1.813%)
Market Cap: £32.61m
PCA Live PriceLast checked at - London Stock Exchange

Intraday Palace Capital Share Chart

DISPOSALS, DEBT AND CASH UPDATE

11 Apr 2025 13:30

RNS Number : 7059E
Palace Capital PLC
11 April 2025
 

11 April 2025

Palace Capital plc

("Palace Capital" or the "Company")

DISPOSALS, DEBT AND CASH UPDATE

Palace Capital (LSE: PCA) announces an update on disposals, debt and cash covering the period since it announced its Interim Results on 14 November 2024. A more in-depth trading update will be provided to the market later in the month.

 

Disposals

· The Company has completed on the sale of two investment properties for £14.8 million which, after adjusting for rent top ups, is 9.6% above the March 2024 valuation. The sales comprise:

HQ Office, York, a freehold, multi-let building for a gross price of £10.0 million to a retained client of STR Capital Partners, at a 9.0% NIY. The net sales price is in line with the March 2024 valuation.

Units 5&6b, Broad Street Plaza, Halifax, on a long leasehold interest for £4.8 million to Calderdale and Huddersfield NHS Foundation Trust, at a 7.5% NIY and 38% ahead of the March 2024 valuation. Additionally, the sale includes the removal of a seven year annual uncapped service charge shortfall landlord liability, the value of which is estimated at £0.4 million.

 

· The Company has now also completed on the sale of Nicholson Gate, Fareham, for a net price of £3.1 million, as previously announced.

 

· Sales activity at Hudson Quarter, York, has been muted since November 2024 due to wider economic uncertainty but the final three bedroom penthouse apartment has now been sold for the asking price of £0.8 million, 2.2% ahead of the March 2024 valuation. Ten units remain for sale and we anticipate further sales in the coming months.

 

 

Debt and Cash Position

· In line with the terms of the loan agreement with Scottish Widows, the Company repaid the outstanding £8.0 million loan (£7.9 million net of the loan break gain) in March 2025, in advance of the completion of the sale of the NHS units at Halifax. The Company is now debt free and the portfolio is entirely unencumbered.

 

· The Company has been in a net cash position since April 2024 and currently has cash of £32.1 million, including £1.1 million relating to the quarterly dividend to be paid on 22 April 2025, as previously announced.

 

 

Commenting on today's update, Steven Owen, Executive Chairman said:

"Since the announcement of our interim results in November 2024, we have continued to progress our disposal strategy and are now in a stronger cash position having repaid the remaining loan, resulting in the portfolio being entirely unencumbered.

"At an operational level, Palace Capital continues to make good progress with its asset management activities and the management of its cost base. The Company will provide additional detail on these and the strategy for its remaining properties in a trading update expected to be announced later this month. Following discussions with shareholders, we expect to announce details of a further significant return of capital, likely through another tender offer, in due course."

 

Palace Capital plc Steven Owen, Executive Chairman info@palacecapitalplc.com

Financial PR FTI ConsultingDido Laurimore / Giles BarrieTel: +44 (0)20 3727 1000 palacecapital@fticonsulting.com

 

This announcement contains inside information for the purposes of Article 7 of the UK version of the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAPLFFSDSEEA
Date   Source Headline
27th May 20264:57 pmRNSHolding(s) in Company
1st May 20261:45 pmRNSTotal Voting Rights
24th Apr 20269:15 amRNSHolding(s) in Company
24th Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Apr 20267:00 amRNSFurther Share Buyback Programme
21st Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Apr 20263:03 pmRNSHolding(s) in Company
17th Apr 20267:00 amRNSShare Buyback Programme
16th Apr 20267:00 amRNSPORTFOLIO VALUATION AS AT 31 MARCH 2026
2nd Apr 20267:00 amRNSHolding(s) in Company
19th Mar 20267:00 amRNSDividend Declaration
4th Mar 20263:02 pmRNSHolding(s) in Company
9th Feb 20267:00 amRNSDisposal Update
23rd Jan 20264:30 pmRNSWithdrawal of Meeting Notice and Board Changes
8th Jan 20267:00 amRNSRESPONSE TO LAKESTREET CAPITAL’S ANNOUNCEMENT
5th Jan 202612:15 pmRNSResponse to Lakestreet Capital Partners AG
5th Jan 20267:00 amRNSLAKESTREET DEMANDS CHANGE AT PALACE CAPITAL
4th Dec 20259:01 amRNSHolding(s) in Company
4th Dec 20259:00 amRNSHolding(s) in Company
1st Dec 202512:47 pmRNSHolding(s) in Company
1st Dec 202512:45 pmRNSHolding(s) in Company
27th Nov 20251:32 pmRNSDividend Declaration
27th Nov 20257:00 amRNSInterim Results
5th Nov 202511:18 amRNSHolding(s) in Company
5th Nov 202511:00 amRNSHolding(s) in Company
28th Oct 20257:00 amRNSHolding(s) in Company
25th Sep 20257:00 amRNSChange of Broker
18th Sep 20257:00 amRNSDividend Declaration
12th Sep 202512:02 pmRNSHolding(s) in Company
10th Sep 202512:07 pmRNSHolding(s) in Company
4th Sep 20251:59 pmRNSHolding(s) in Company
3rd Sep 202511:19 amRNSHolding(s) in Company
3rd Sep 20257:00 amRNSTransaction in Own Shares
28th Aug 20257:00 amRNSResult of Tender Offer
26th Aug 202512:32 pmRNSResult of General Meeting
31st Jul 20257:00 amRNSProposed Tender Offer & Notice of General Meeting
9th Jul 202511:00 amRNSResult of AGM
6th Jun 202511:00 amRNSAnnual Report and Notice of Annual General Meeting
5th Jun 20257:00 amRNSPreliminary Results for year ended 31 March 2025
30th Apr 20257:00 amRNSTRADING AND STRATEGY UPDATE
17th Apr 20257:00 amRNSHolding(s) in Company
11th Apr 20251:30 pmRNSDISPOSALS, DEBT AND CASH UPDATE
11th Mar 20257:00 amRNSDividend Declaration
10th Dec 20241:12 pmRNSHolding(s) in Company
15th Nov 202412:59 pmRNSHolding(s) in Company
14th Nov 20247:00 amRNSInterim Results
12th Nov 202412:00 pmRNSNotice of Results
9th Oct 202412:16 pmRNSHolding(s) in Company
24th Sep 202412:00 pmRNSDirector/PDMR Shareholding
19th Sep 20247:00 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.